Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants
- PMID: 41143802
- PMCID: PMC12560025
- DOI: 10.1001/jamainternmed.2025.5465
Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants
Plain language summary
This observational study assesses the durability of protection provided by updated COVID-19 vaccines over a 7-month period, during which circulating SARS-CoV-2 variants were predominantly JN.1 descendants.
Conflict of interest statement
Comment in
- doi: 10.1001/jamainternmed.2025.5462
References
-
- FDA approves and authorizes updated mRNA COVID-19 vaccines to better protect against currently circulating variants. Press release. US Food and Drug Administration. Published August 22, 2024. Accessed September 25, 2025. https://www.fda.gov/news-events/press-announcements/fda-approves-and-aut...
-
- FDA authorizes updated Novavax COVID-19 vaccine to better protect against currently circulating variants. Press release. US Food and Drug Administration. Published August 30, 2024. Accessed September 25, 2025. https://www.fda.gov/news-events/press-announcements/fda-authorizes-updat...
LinkOut - more resources
Full Text Sources
Miscellaneous
